GNW - Genworth Financial, Inc.
NYSE
->
Financial Services
->
Insurance—Life
Richmond,
United States
Type: Equity
GNW price evolution
GNW
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1932 | $1952 | $2215 | |
| Short term investments | ||||
| Net receivables | $17713 | $18288 | $19025 | |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $197 | $197 | $198 | |
| Total noncurrent assets | ||||
| Total investments | $58359 | $59062 | $59751 | |
| Total assets | $90760 | $87543 | $89192 | $90817 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | $130 | $139 | $149 | |
| Short long term debt | ||||
| Total current liabilities | $48 | |||
| Long term debt | $1548 | $1564 | $1579 | $1584 |
| Total noncurrent liabilities | ||||
| Total debt | $1564 | $1579 | $1584 | |
| Total liabilities | $82449 | $78190 | $80313 | $82482 |
| Shareholders' equity | ||||
| Retained earnings | $1512 | $1428 | $1352 | $1213 |
| Other shareholder equity | -$466 | -$1687 | -$2094 | -$2555 |
| Total shareholder equity | $8459 | $8006 | $7480 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2215 | $1799 | $1571 | $2656 |
| Short term investments | ||||
| Net receivables | $19025 | $16435 | $16813 | $16819 |
| Inventory | ||||
| Total current assets | ||||
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $198 | $241 | $143 | $200 |
| Total noncurrent assets | ||||
| Total investments | $59751 | $58948 | $72278 | $77240 |
| Total assets | $90817 | $86442 | $99171 | $105747 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | $149 | $584 | $672 | $1968 |
| Short long term debt | ||||
| Total current liabilities | $48 | $51 | $45 | |
| Long term debt | $1584 | $1611 | $1899 | $3548 |
| Total noncurrent liabilities | ||||
| Total debt | $1584 | $1611 | $1899 | $3548 |
| Total liabilities | $82482 | $76458 | $82905 | $89927 |
| Shareholders' equity | ||||
| Retained earnings | $1213 | $3098 | $2490 | $1584 |
| Other shareholder equity | -$2555 | $1206 | $3861 | $4425 |
| Total shareholder equity | $7480 | $9984 | $15510 | $15318 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1769 | |||
| Cost of revenue | $1307 | |||
| Gross Profit | $462 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $229 | |||
| Total operating expenses | $289 | |||
| Operating income | $173 | |||
| Income from continuing operations | ||||
| EBIT | $138 | |||
| Income tax expense | $32 | |||
| Interest expense | $30 | |||
| Net income | ||||
| Net income | $76 | |||
| Income (for common shares) | $76 | |||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7488 | $7507 | $8658 | |
| Cost of revenue | $5861 | $4745 | $5940 | |
| Gross Profit | $1627 | $2762 | $2718 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $942 | $1371 | $988 | |
| Total operating expenses | $1206 | $1678 | $1485 | |
| Operating income | $421 | $1084 | $1233 | |
| Income from continuing operations | ||||
| EBIT | $298 | $954 | $650 | |
| Income tax expense | $104 | $239 | $270 | |
| Interest expense | $118 | $106 | $202 | |
| Net income | ||||
| Net income | $76 | $609 | $178 | |
| Income (for common shares) | $76 | $609 | $178 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $76 | $139 | -$212 | |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11 | $14 | $12 | |
| Total cash flows from operations | $7 | -$107 | $147 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $276 | $160 | $365 | |
| Total cash flows from investing | $641 | $258 | $143 | $348 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$36 | -$63 | -$35 | |
| Net borrowings | -$27 | -$6 | -$21 | |
| Total cash flows from financing | -$860 | -$285 | -$299 | -$273 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$158 | -$20 | -$263 | $222 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $76 | $609 | $904 | $178 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | $270 | |||
| Stock-based compensation | $49 | $37 | $40 | $40 |
| Total cash flows from operations | $597 | $1049 | $437 | $1960 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $1316 | $733 | $693 | -$886 |
| Total cash flows from investing | $1261 | $733 | $896 | -$1153 |
| Financing activities | ||||
| Dividends paid | -$9 | |||
| Sale and purchase of stock | -$296 | -$64 | ||
| Net borrowings | -$32 | -$297 | -$1541 | -$76 |
| Total cash flows from financing | -$1443 | -$1554 | -$2419 | -$1507 |
| Effect of exchange rate | $1 | $1 | $15 | |
| Change in cash and equivalents | $416 | $228 | -$1085 | -$685 |
News
Fundamentals
| Market cap | $2.79B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 428.43M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 11.03 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |